Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, West Virginia 26505, USA.
Toxicol Sci. 2010 Jun;115(2):435-43. doi: 10.1093/toxsci/kfq054. Epub 2010 Feb 22.
Although ortho-phthalaldehyde (OPA) has been suggested as an alternative to glutaraldehyde for the sterilization and disinfection of hospital equipment, the toxicity has not been thoroughly investigated. The purpose of these studies was to evaluate the irritancy and sensitization potential of OPA. The EpiDerm Skin Irritation Test was used to evaluate in vitro irritancy potential of OPA and glutaraldehyde. Treatment with 0.4125 and 0.55% OPA induced irritation, while glutaraldehyde exposure at these concentrations did not. Consistent with the in vitro results, OPA induced irritancy, evaluated by ear swelling, when mice were treated with 0.75%. Initial evaluation of the sensitization potential was conducted using the local lymph node assay at concentrations ranging from 0.005 to 0.75%. A concentration-dependent increase in lymphocyte proliferation was observed with a calculated EC3 value of 0.051% compared to that of 0.089%, previously determined for glutaraldehyde. Immunoglobulin (Ig) E-inducing potential was evaluated by phenotypic analysis of draining lymph node (DLN) cells and measurement of total and specific serum IgE levels. The 0.1 and 0.75% exposed groups yielded significant increases in the IgE+B220+ cell population in the lymph nodes while the 0.75% treated group demonstrated significant increases in total IgE, OPA-specific IgE, and OPA-specific IgG(1). In addition, significant increases in interleukin-4 messenger RNA and protein expression in the DLNs were observed in OPA-treated groups. The results demonstrate the dermal irritancy and allergic potential of OPA and raise concern about the proposed/intended use of OPA as a safe alternative to glutaraldehyde.
虽然邻苯二甲醛(OPA)已被提议作为戊二醛的替代品,用于医院设备的消毒和灭菌,但毒性尚未得到彻底研究。这些研究的目的是评估 OPA 的刺激性和致敏潜力。使用 EpiDerm 皮肤刺激性测试评估 OPA 和戊二醛的体外刺激性潜力。用 0.4125%和 0.55%OPA 处理会引起刺激,而在这些浓度下接触戊二醛则不会。与体外结果一致,当用 0.75%OPA 处理时,通过耳肿胀评估,OPA 会引起刺激性。最初的致敏潜力评估使用局部淋巴结测定法在 0.005 至 0.75%的浓度范围内进行。观察到淋巴细胞增殖呈浓度依赖性增加,与先前确定的戊二醛相比,计算得出的 EC3 值为 0.051%。免疫球蛋白(Ig)E 诱导潜力通过引流淋巴结(DLN)细胞的表型分析和总血清 IgE 水平及特异性 IgE 水平的测量来评估。暴露于 0.1%和 0.75%OPA 的组中,IgE+B220+细胞群在淋巴结中显著增加,而 0.75%处理组的总 IgE、OPA 特异性 IgE 和 OPA 特异性 IgG(1)水平显著增加。此外,在 OPA 处理组的 DLNs 中观察到白细胞介素-4 信使 RNA 和蛋白质表达的显著增加。结果表明 OPA 具有皮肤刺激性和致敏潜力,并对拟议/预期将 OPA 用作戊二醛的安全替代品表示关注。